Sydney H. Hamet
Corporate Officer/Principal presso DAVA Pharmaceuticals, Inc.
Profilo
Sydney H.
Hamet is Vice President of Quality Assurance for DAVA Pharmaceuticals, Inc. Previously, he served as Commissioned Officer of the U.S.
Public Health Service.
Prior to joining DAVA in October 2007, Mr. Hamet held quality manufacturing responsibilities at Ferring Pharmaceuticals, Inc. He joined IVAX as Director of QA from 1998 to 1999.
Mr. Hamet was Senior Director of QA for Par Pharmaceuticals and Senior Director of Compliance from 1989 to 1998.
He began his pharmaceutical industry career in 1983 as the Director of RA/QA at Goldline Laboratories (now IVAX).
Mr. Hamet has over 20 years of pharmaceutical regulatory affairs, compliance and quality assurance experience.
Posizioni attive di Sydney H. Hamet
| Società | Posizione | Inizio |
|---|---|---|
DAVA Pharmaceuticals, Inc.
 DAVA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DAVA Pharmaceuticals, Inc. develops and markets pharmaceutical products. It offers generic and brand pharmaceutical products which include acyclovir capsules, acyclovir capsules, oxycodone hydrochloride extended-release tablets, glyburide tablets, hydrochlorothiazide tablets, and oral suspensions. The company was founded by Aram Moezinia in 2004 and is headquartered in Fort Lee, NJ. | Corporate Officer/Principal | 01/10/2007 |
Precedenti posizioni note di Sydney H. Hamet
| Società | Posizione | Fine |
|---|---|---|
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1985 and is headquartered in Weston, FL. | Direttore/Membro del Consiglio | 01/01/1999 |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
DAVA Pharmaceuticals, Inc.
DAVA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DAVA Pharmaceuticals, Inc. develops and markets pharmaceutical products. It offers generic and brand pharmaceutical products which include acyclovir capsules, acyclovir capsules, oxycodone hydrochloride extended-release tablets, glyburide tablets, hydrochlorothiazide tablets, and oral suspensions. The company was founded by Aram Moezinia in 2004 and is headquartered in Fort Lee, NJ. | Health Technology |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
IVAX LLC
IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1985 and is headquartered in Weston, FL. | Health Technology |
- Borsa valori
- Insiders
- Sydney H. Hamet
